Earnings History Data for Minerva Neurosciences (NERV) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Minerva Neurosciences

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The Company's pipeline will initially target the treatment of schizophrenia, major depressive disorder (MDD), insomnia, and Parkinson's disease. Its product candidates include MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences, Inc. is based in Cambridge, MA, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
22-02-2024	PM		NERV	Minerva Neurosciences	62.00	-1.19	-0.88	0.00		7.41	-1.39 (-15.81%)	8.63	-0.17 (-1.93%)	1.50 - 13.49	201,938	80,000	2,997

07-11-2023	PM		NERV	Minerva Neurosciences	39.00	-1.03	-0.77	0.00	Minerva Neurosciences GAAP EPS of -$1.03 misses by $0.26 [11/7/2023 8:20 AM]	5.40	0.0 (0.00%)	5.30	-0.10 (-1.85%)	1.26 - 13.22	13,108	20,000	266
Minerva Neurosciences GAAP EPS of -$1.03 misses by $0.26 [11/7/2023 8:20 AM]
15-05-2023	PM	8:00 AM ET (May 15)	NERV	Minerva Neurosciences, Inc	41.39	-1.31	-1.63	-1.84	Minerva Neurosciences GAAP EPS of -$1.31 [5/15/2023 7:38 AM]	6.43	-0.84 (-11.55%)	7.28	0.01 (0.14%)	1.26 - 15.27	120,659	830,000	1,362
Minerva Neurosciences GAAP EPS of -$1.31 [5/15/2023 7:38 AM]
08-03-2023	PM	8:00 AM ET (Mar 8)	NERV	Minerva Neurosciences, Inc	12.23	-1.26	-1.35	-0.96	Minerva Neurosciences GAAP EPS of -$1.26 misses by $0.34 [3/8/2023 7:31 AM]	1.86	-0.16 (-8.14%)	0.0	0.0 (0.00%)	1.26 - 15.27	68,146	20,000	0
Minerva Neurosciences GAAP EPS of -$1.26 misses by $0.34 [3/8/2023 7:31 AM]
09-11-2022	PM	8:00 AM ET (Nov 9)	NERV	Minerva Neurosciences, Inc	14.37	-1.29	-1.46	-1.76	Minerva Neurosciences GAAP EPS of -$1.29 beats by $0.03 [11/9/2022 8:04 AM]	3.30	0.30 (10.18%)	3.12	0.12 (4.17%)	2.51 - 15.27	1,831,930	170,000	3,985
Minerva Neurosciences GAAP EPS of -$1.29 beats by $0.03 [11/9/2022 8:04 AM]
09-08-2022	PM	8:30 AM ET (Aug 9)	NERV	Minerva Neurosciences, Inc	15.11	-1.63	-1.84	2.00	Minerva Neurosciences GAAP EPS of -$1.63 [8/9/2022 8:30 AM]	3.64	-1.09 (-23.04%)	4.54	-0.19 (-4.02%)	2.51 - 17.04	489,926	4,050,000	12,999
Minerva Neurosciences GAAP EPS of -$1.63 [8/9/2022 8:30 AM]
04-05-2022	PM		NERV	Minerva Neurosciences	21.00	-0.23	-0.20	0.00	Minerva Neurosciences GAAP EPS of -$0.23 misses by $0.05 [5/4/2022 8:44 AM]	0.50	0.0 (-0.20%)	0.49	-0.01 (-2.91%)	0.48 - 3.54	64,274	80,000	6,836
Minerva Neurosciences GAAP EPS of -$0.23 misses by $0.05 [5/4/2022 8:44 AM] Minerva Neurosciences Reports First Quarter 2022 Financial Results and Business Updates [May-04-22 08:30AM]
01-03-2022	PM		NERV	Minerva Neurosciences	29.00	-0.12	-0.20	0.00	Minerva Neurosciences GAAP EPS of -$0.50 misses by $0.31 [3/1/2022 7:49 AM]	0.6907	-0.02 (-2.19%)	0.0	0.0 (0.00%)	0.65 - 3.54	69,277	150,000	0
Minerva Neurosciences GAAP EPS of -$0.50 misses by $0.31 [3/1/2022 7:49 AM] Minerva Neurosciences Reports Fourth Quarter 2021 Financial Results and Business Updates [Mar-01-22 07:30AM] Minerva Neurosciences Announces Publication of Roluperidone Phase 3 Study Results in Schizophrenia Bulletin [Feb-28-22 08:30AM] Minerva Neurosciences (NERV) Reports Q4 Loss, Misses Revenue Estimates [Mar-01-22 09:05AM]
08-11-2021	PM	7:30 AM ET (Nov 8)	NERV	Minerva Neurosciences, Inc	61.09	-0.22	-0.22	-0.19	Minerva Neurosciences EPS misses by $0.01 [11/8/2021 7:37 AM]	1.41	0.07 (4.81%)	1.40	0.05 (3.70%)	1.25 - 4.12	205,456	360,000	18,991
Minerva Neurosciences EPS misses by $0.01 [11/8/2021 7:37 AM] Minerva Neurosciences Reports Third Quarter 2021 Financial Results and Business Updates [Nov-08-21 07:30AM] Minerva Neurosciences (NERV) Reports Q3 Loss, Misses Revenue Estimates [Nov-08-21 08:45AM]
02-08-2021	PM	7:30 AM ET (Aug 2)	NERV	Minerva Neurosciences, Inc	82.88	-0.25	-0.17	0.73	Minerva Neurosciences EPS misses by $0.08 [8/2/2021 7:40 AM]	1.82	-0.02 (-1.09%)	1.79	-0.05 (-2.72%)	1.75 - 4.12	350,913	410,000	30,129
Minerva Neurosciences EPS misses by $0.08 [8/2/2021 7:40 AM] Minerva Neurosciences Reports Second Quarter 2021 Financial Results and Business Updates [Aug-02-21 07:30AM] Minerva Neurosciences (NERV) Reports Q2 Loss, Lags Revenue Estimates [Aug-02-21 08:55AM]
12-05-2021	PM	7:30 AM ET (May 12)	NERV	Minerva Neurosciences, Inc	96.55	-0.21	0.20	-0.31	Minerva Neurosciences EPS misses by $0.54 [5/12/2021 7:31 AM]	2.58	0.35 (15.70%)	2.63	0.40 (17.94%)	1.81 - 15.21	51,433,052	900,000	5,345,793
Minerva Neurosciences shares surge on late-stage schizophrenia study data [5/11/2021 4:49 PM] Minerva Neurosciences EPS misses by $0.54 [5/12/2021 7:31 AM] Minerva surges 27% following positive phase 3 data for schizophrenia candidate [5/12/2021 9:50 AM] Minerva Neurosciences Announces the Results of the Phase 3 Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia Following the Completion of the 40-Week Open-Label Extension [May-11-21 04:15PM] Minerva Neurosciences, Inc. to Host Earnings Call [May-12-21 06:45AM] Minerva Neurosciences Reports First Quarter 2021 Financial Results and Business Updates [May-12-21 07:30AM] Thinking about buying stock in Minerva Neurosciences, Fubotv, Lucira Health, Biomerica, or Comstock Mining? [May-12-21 08:30AM] Minerva Shares Surge As Schizophrenia Candidate Shows Long Term Improvement In Negative Symptoms, Functioning [May-12-21 06:59AM] Minerva (NERV) Soars on Promising Schizophrenia Study Data [May-12-21 10:03AM] Minerva Shares Soar on Positive Schizophrenia Drug Trial [May-12-21 07:20AM] Biotech Stock Roundup: REGN's Q1 Earnings Update, MRNA's Vaccine Data & More [May-12-21 02:35PM]
08-03-2021	PM	7:30 AM ET (Mar 8)	NERV	Minerva Neurosciences, Inc	132.29	-0.17	-0.21	-0.77	Minerva Neurosciences EPS beats by $0.02 [3/8/2021 7:34 AM]	3.21	0.35 (12.24%)	2.95	0.09 (3.15%)	1.81 - 15.22	538,884	460,721	3,112
Minerva Neurosciences EPS beats by $0.02 [3/8/2021 7:34 AM]
02-11-2020	PM	7:30 AM ET (Nov 2)	NERV	Minerva Neurosciences, Inc	133.50	-0.19	-0.22	-0.36	Minerva Neurosciences EPS beats by $0.03 [11/2/2020 7:37 AM]	3.09	-0.12 (-3.74%)	3.29	0.08 (2.49%)	1.81 - 15.22	489,321	369,621	1,221

03-08-2020	PM	7:30 AM ET (Aug 3)	NERV	Minerva Neurosciences, Inc	141.97	0.73	-0.30	-0.32	Minerva Neurosciences EPS of $0.73 [8/3/2020 7:36 AM]	3.70	0.21 (6.03%)	3.73	0.24 (7.03%)	1.81 - 15.22	1,848,522	1,030,561	662,898